Supplementation required for surgical anaesthesia · patients with regional anaesthesia of the lower arm
infraclavicular block showed no clear difference in supplementation required to achieve adequate surgical anaesthesia compared with all other brachial plexus blocks (high certainty).
1 finding from 1 review
Tourniquet pain · patients with regional anaesthesia of the lower arm
infraclavicular block leads to lower tourniquet pain compared with all other brachial plexus blocks (high certainty).
1 finding from 1 review
Onset time of adequate surgical anaesthesia (minutes) · patients with regional anaesthesia of the lower arm
1 finding from 1 review
Block performance time (minutes) ‐ multiple‐injection axillary block · patients with regional anaesthesia of the lower arm
1 finding from 1 review
Block performance time (minutes) ‐ mid‐humeral block · patients with regional anaesthesia of the lower arm
1 finding from 1 review
Mortality－At any time · people who underwent a lower limb revascularisation
Neuraxial showed no clear difference in mortality－At any time compared with general anaesthesia (low certainty).
1 finding from 1 review
Myocardial infarction ‐ Spinal anaesthesia · people who underwent a lower limb revascularisation
Neuraxial showed no clear difference in myocardial infarction－Spinal anaesthesia compared with general anaesthesia (low certainty).
1 finding from 1 review
Myocardial infarction ‐ Epidural anaesthesia · people who underwent a lower limb revascularisation
Neuraxial showed no clear difference in myocardial infarction－Epidural anaesthesia compared with general anaesthesia (low certainty).
1 finding from 1 review
Amputation rate ‐ Spinal anaesthesia · people who underwent a lower limb revascularisation
Neuraxial showed no clear difference in amputation rate－Spinal anaesthesia compared with general anaesthesia (low certainty).
1 finding from 1 review
Amputation rate ‐ Epidural anaesthesia · people who underwent a lower limb revascularisation
Neuraxial showed no clear difference in amputation rate－Epidural anaesthesia compared with general anaesthesia (low certainty).
1 finding from 1 review
Pneumonia · people who underwent a lower limb revascularisation
It is very uncertain whether neuraxial changes pneumonia compared with general anaesthesia (very low certainty).
1 finding from 1 review
Overall survival among all patients · resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus
Perioperative chemotherapy leads to lower overall survival among all patients compared with primary surgery (high certainty).
1 finding from 1 review
Presence of tumor‐free resection margin · resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus
Perioperative chemotherapy showed no clear difference in presence of tumor‐free resection margin compared with primary surgery (moderate certainty).
1 finding from 1 review
Tumor stage at resection (T0 to T2 vs T3 to T4) · resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus
Perioperative chemotherapy probably leads to higher tumor stage at resection (T0 to T2 vs T3 to T4) compared with primary surgery (moderate certainty).
1 finding from 1 review
Tumor stage at resection (N0 vs N+) · resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus
Perioperative chemotherapy may leads to higher tumor stage at resection (N0 vs N+) compared with primary surgery (low certainty).
1 finding from 1 review
Postoperative morbidity RD · resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus
1 finding from 1 review
Postoperative mortality RD · resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus
1 finding from 1 review
Disease-free survival · resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus
Perioperative chemotherapy showed no clear difference in disease‐free survival (landmark time 6 months) compared with primary surgery (high certainty).
1 finding from 1 review
Overall survival by type of data ‐ Individual patient data · resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus
Perioperative chemotherapy leads to lower overall survival by type of data ‐ Individual patient data compared with primary surgery (high certainty).
1 finding from 1 review
Overall survival by type of data ‐ Aggregated data · resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus
Perioperative chemotherapy probably leads to lower overall survival by type of data ‐ Aggregated data compared with primary surgery (moderate certainty).
1 finding from 1 review